Global Implantable Cardiac Monitors Market Trends, Applications, Analysis, Growth, and Forecast: 2018 to 2027

MarketResearch.biz delivers in-depth insights on the global implantable cardiac monitors market in its upcoming report titled, “Global Implantable Cardiac Monitors Market Trends, Applications, Analysis, Growth, and Forecast: 2018 to 2027”. The global implantable cardiac monitors market is estimated to register a CAGR of X.X% in terms of value during forecast period 2018–2027. The report offers in-depth insights, revenue details, and other vital information regarding the target market, and the various trends, drivers, restraints, opportunities, and threats till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global implantable cardiac monitors market report has been segmented on the basis of indication, end user, and region

Request Covid - 19 Impact

Implantable cardiac monitors (ICMs) are used for continuously monitoring of patient’s heart and perform real-time analysis. It is generally placed in the left parasternal area of the chest, however it can be placed in some other parts of body especially for younger patients, to minimize psychological impact of surgical scar in anterior chest region without impairing the performance of the device.

Technological advancements in cardiac monitors devices such as miniaturization and easier implant procedure demand for implantable cardiac monitors for continuous monitoring of heart for early detection of clinical events such as cardiac arrhythmias and atrial fibrillation are major factors driving growth of the global implantable cardiac monitors market. In addition, increasing incidences of cardiovascular diseases and remote monitoring help doctors for follow-up of patients for better outcomes, and these factors are expected to boost growth of the market. Moreover, use of implantable cardiac monitors for monitoring epilepsy disorder is expected to support growth of the global implantable cardiac monitors market.

However, high cost of implantable cardiac monitor devices is expected to restrain growth of the global implantable cardiac monitors market. In addition, risks such as infection at surgical site and limitation to device such as magnetic and electromagnetic radiation is expected to hamper growth of the global implantable cardiac monitors market.

Development of cost effective implantable cardiac monitors devices and increasing awareness about devices is expected to create new opportunities for players operating in the global implantable cardiac monitors market.

North America market is expected to dominate in the global implantable cardiac monitors market with higher market share as compared to other regional markets, and is expected to continue its dominance during the forecast period. This can be attributed to favorable reimbursement policies and presence of prominent market players operating in countries in this region. Europe market accounts for second-largest revenue share in the global implantable cardiac monitors market, followed by markets in Asia Pacific, Latin America and Middle East & Africa respectively. The market in Asia Pacific is projected to register fastest revenue CAGR over the forecast period, owing increasing government expenditure for development of healthcare sector in emerging economies in this region.

Global Implantable Cardiac Monitors Market Segmentation:

By Indication:

• Cardiac Arrhythmias
• Atrial Fibrillation
• Epilepsy & Unexplained Falls

By End User:

• Hospitals
• Cardiac Center & Clinics
• Ambulatory Surgical Centers (ASCs)

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

• Abbott Laboratories
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• Edwards Lifescience Corporation
• General Electric Company
• Koninklijke Philips N.V.
• LivaNova PLC
• Medtronic plc
• Nihon Kohden Corporation
• Astellas Pharma US, Inc.